Difference between revisions of "Comment Resolutions"

From QIBA Wiki
Jump to navigation Jump to search
m
 
(46 intermediate revisions by 3 users not shown)
Line 1: Line 1:
−
Comments received during Public Comment, Technical Confirmation, or during a Profile ballot, are reviewed by the originating Biomarker Committee.   
+
Comments received during Public Comment, Clinically Feasible (formerly Technical) Confirmation, or during a Profile ballot, are reviewed by the originating Biomarker Committee.   
  
 
Per the [[Process#Profile_Creation_Process|QIBA Process]], committees record how each '''[[Public Comment Process|collected comment was resolved]]''' and those resolutions are posted here.  
 
Per the [[Process#Profile_Creation_Process|QIBA Process]], committees record how each '''[[Public Comment Process|collected comment was resolved]]''' and those resolutions are posted here.  
Line 12: Line 12:
 
| colspan="4" align="center" style="background:#dddddd" | '''CT Profiles'''
 
| colspan="4" align="center" style="background:#dddddd" | '''CT Profiles'''
 
|-
 
|-
−
| [[Media:QIBA_CT_Vol_LungNoduleAssessmentInCTScreening_v5-2-16b.docx| CT Small Lung Nodule Screening 2016-06-01]]
+
| [[Media:QIBA CT Vol LungNoduleAssessmentInCTScreening v5-2-16b.docx| CT Small Lung Nodule Screening 2016-06-01]]
 
| Public Comment
 
| Public Comment
 
| 2016.09
 
| 2016.09
−
| [[Media:2018-06-15 v9 QIBA SLN CommentsAndResolutions.xlsx|Public Comment Resolutions 2018-06-15]]  
+
| [[Media:2018-06-15 v9 QIBA SLN CommentsAndResolutions.xlsx|Public Comment Resolutions 2018-06-15]]
 
|-
 
|-
−
| [[Media:QIBA_CTVol_TumorVolumeChangeProfile_Consensus-20161121b.pdf| CT Tumor Volumetry for Advanced Disease 2016-11-21b]]  
+
| [[Media:QIBA CTVol TumorVolumeChangeProfile Consensus-20161121b.pdf| CT Tumor Volumetry for Advanced Disease 2016-11-21b]]
 
| Technical Confirmation
 
| Technical Confirmation
 
| 2017.02
 
| 2017.02
 
| [https://docs.google.com/spreadsheets/d/1cyz0frvELb6Tq1EHjpHxnvjeUxotExnJ3OrKPdIa30U/edit?usp=sharing Technical Confirmation Resolutions 2018-02-25]
 
| [https://docs.google.com/spreadsheets/d/1cyz0frvELb6Tq1EHjpHxnvjeUxotExnJ3OrKPdIa30U/edit?usp=sharing Technical Confirmation Resolutions 2018-02-25]
 
|-
 
|-
−
| [[Media:QIBA_CTA_Profile_as_of_2019-Feb-29.pdf| CT Atherosclerosis 2019-02-29]]
+
| [[Media:QIBA CTA Profile as of 2020-March-10.pdf| CT Atherosclerosis 2020-03-10]]
 
| Public Comment
 
| Public Comment
 
| 2019.06.03
 
| 2019.06.03
−
| [[Media:QIBA_CTA_Comments_all resolved.xlsx| Public Comment Resolutions 2020-03-12]]
+
| [[Media:QIBA CTA Comments all resolved.xlsx| Public Comment Resolutions 2020-03-12]]
 
|-
 
|-
−
| [[Media:QIBA_CT_Lung_Density_Profile_090319-clean.pdf | CT Lung Density 2019-09-03]]
+
| [[Media:Atherosclerosis Biomarkers Profile 2023Mar28.pdf| CT Atherosclerosis 2023-03-28]]
 +
| Clinically Feasible
 +
| 2023.03.07
 +
| [[Media:CTA Profile Clinically Feasible Comment Resolutions.2023Mar28.pdf|Clinically Feasible Comment Resolutions 2023-03-28]]
 +
|-
 +
| [[Media:QIBA CT Lung Density Profile 090420-clean.pdf| CT Lung Density 2020-09-04]]
 
| Public Comment
 
| Public Comment
 
| 2019.10.16
 
| 2019.10.16
−
| '''Resolving Feedback'''
+
|[[Media:QIBA Lung Density Comments resolved.xlsx| Public Comment Resolutions 2020-09-04]]
 
|-
 
|-
−
| [[Media:QIBA_CT_Vol_SmallLungNoduleAssessmentInCTScreening_2018.11.18-clean-3.pdf|CT Small Lung Nodule Screening 2018-11-18]]
+
|[[Media:QIBA CT Vol SmallLungNoduleAssessmentInCTScreening 2018.11.18-clean-3.pdf|CT Small Lung Nodule Screening 2018-11-18]]
 
| Technical Confirmation
 
| Technical Confirmation
 
| 2020.04
 
| 2020.04
−
| '''Resolving Feedback'''
+
|[[Media:CT Small Lung Nodule Profile Clinically Feasible Comment Resolutions.2023Aug18.pdf|Clinically Feasible Comment Resolutions 2023-08-18]]
 
|-
 
|-
 
| colspan="4" align="center" style="background:#dddddd" | '''MR Profiles'''
 
| colspan="4" align="center" style="background:#dddddd" | '''MR Profiles'''
 
|-
 
|-
−
| [[Media:QIBADWIProfilev1.45_20170427_v5_accepted_linenumbers.pdf| MR DWI 2017-04-27]]
+
| [[Media:Draft-MRE-QIBAProfile-2017-07-28 clean.pdf| MR Elastography 2017-08-15]]
−
| Public Comment
 
−
| 2017.08.25
 
−
| '''Resolving Feedback'''
 
−
|-
 
−
| [[Media:Draft-MRE-QIBAProfile-2017-07-28_clean.pdf| MR Elastography 2017-08-15]]
 
 
| Public Comment
 
| Public Comment
 
| 2017.09.15
 
| 2017.09.15
−
| '''Resolving Feedback'''
+
| [[Media:MRE Profile Public Comments 2018 02 08.pdf| Public comment Resolutions]]
 
|-
 
|-
−
| [[Media:QIBA_fMRI_Profile_1_PC-rev1.pdf| fMRI Sensorimotor 2017-06-19]]
+
| [[Media:QIBA fMRI Profile 1 PC-rev1.pdf| fMRI Sensorimotor 2017-06-19]]
 
| Public Comment
 
| Public Comment
 
| 2017.12.31
 
| 2017.12.31
 
| '''Resolving Feedback'''
 
| '''Resolving Feedback'''
 
|-
 
|-
−
| [[Media:QIBADWIProfile_as_of_2019-Feb-05.pdf| MR DWI 2019-02-05]]
+
| [[Media:QIBADWIProfile as of 2019-Feb-05.pdf| MR DWI 2019-02-05]]
 
| Public Comment #2
 
| Public Comment #2
 
| 2019.04.05
 
| 2019.04.05
 
| [[Media:QIBA DWI Profile-Public Comment--2 Resolutions.pdf| Public Comment Resolutions]]
 
| [[Media:QIBA DWI Profile-Public Comment--2 Resolutions.pdf| Public Comment Resolutions]]
 
|-
 
|-
−
| [[Media:QIBA_DSC-MRI_Stage1_Profile.pdf|MR Dynamic Susceptibility Contrast (DSC-MRI) 2020-01-29]]
+
| [[Media:QIBA DSC-MRI Stage1 Profile.pdf|MR Dynamic Susceptibility Contrast (DSC-MRI) 2020-01-29]]
 
| Public Comment
 
| Public Comment
 
| 2020.05.15
 
| 2020.05.15
−
| '''Resolving Feedback'''
+
| [[Media:QIBA DSC-MRI Public Comment Resolutions v2020Oct.9.pdf| Public Comment Resolutions]]
 +
|-
 +
| [[Media:QIBA Profile MSK-Cartilage-Stage1 Profile.pdf|MR MSK cartilage compositional biomarkers (T1ρ,T2) 2020-05-18]]
 +
| Public Comment
 +
| 2020.10.29
 +
| [[Media:QIBA MSK BC Public Comment Resolutions.pdf| Public Comment Resolutions]]
 +
|-
 +
| [[Media:QIBA DCE-Profile - v2.0 - Consensus Document.pdf|MR DCE-MRI Quantification (DCEMRI-Q) 2023-12-06]]
 +
| Consensus
 +
| 2023.12-06
 +
| [[Media:QIBA DCE-MRI Public Comment Resolutions.pdf| Public Comment Resolutions]]
 +
|-
 +
| [[Media:MRE-QIBAProfile-2022-02-14-TECHNICALLY-CONFIRMED.pdf| MR Elastography of the Liver 2022-02-14]]
 +
| Technical Confirmation
 +
| 2021.12.16
 +
| [[Media:QIBATechnicalConfirmationResolutions MRE.pdf| Technical Confirmation Resolutions 2022-02-14]]
 +
|-
 +
| [[Media:QIBA DWIProfile Stage3 15Dec2022 v3.pdf| MR Diffusion-Weighted Imaging (DWI) of the Apparent Diffusion Coefficient (ADC) 2022-12-15]]
 +
| Clinically Feasible
 +
| 2022.12.15
 +
| [[Media:QIBA DWI-MR Clinical Feasibility Resolutions.pdf| Clinically Feasible Resolutions 2022-12-15]]
 +
|-
 +
| [[Media:QIBA PDFF Profile Stage2 FINAL.pdf| MR MRI-Based Proton Density Fat Fraction (PDFF) of the Liver 2023-12-04]]
 +
|Consensus
 +
|2023.09.08
 +
| [[Media:QIBA PDFF Public Comment Resolutions.pdf| Public Comment Resolutions 2023-11-14]]
 
|-
 
|-
 
| colspan="4" align="center" style="background:#dddddd" | '''PET/NM Profiles'''
 
| colspan="4" align="center" style="background:#dddddd" | '''PET/NM Profiles'''
Line 69: Line 94:
 
| Public Comment
 
| Public Comment
 
| 2016.12.31
 
| 2016.12.31
−
| [[Media: SPECT Profile Response to Public Comments.v2017 06 06.xlsx | Public Comment Resolutions 2017-06-06]]
+
| [[Media:SPECT Profile Response to Public Comments.v2017 06 06.xlsx| Public Comment Resolutions 2017-06-06]]
 +
|-
 +
| [[Media:QIBA AmyloidPET 15June2017.pdf| PET Amyloid 2019-06-15]]
 +
| Technical Confirmation
 +
| 2021
 +
| [[Media:QIBA PET Amyloid Profile changes.pdf| Technical Confirmation Resolutions, 2022-04-15]]
 
|-
 
|-
−
| [[Media:QIBA_AmyloidPET_15June2017.pdf| PET Amyloid 2019-06-15]]
+
| [[Media:QIBA AmyloidPET 15June2017.pdf| PET Amyloid 2017-06-15]]
−
| Public Comment
+
|Public Comment
−
| 2017.09.15
+
|2017.09.15
−
| [[Media:QIBA_PET_Amyloid Comments_all resolved.xlsx| Public Comment Resolutions 2018-05-02]]
+
|[[Media:QIBA PET Amyloid Comments all resolved.xlsx| Public Comment Resolutions 2018-05-02]]
 
|-
 
|-
−
| [[Media:002.QIBA SPECT Ioflupane Profile v2.0.2019 10 15.pdf | SPECT Ioflupane in Neurodegenerative Disease v2.0, 2019-10-15]]
+
| [[Media:002.QIBA SPECT Ioflupane Profile v2.0.2019 10 15.pdf| SPECT Ioflupane in Neurodegenerative Disease v2.0, 2019-10-15]]
 
| Public Comment
 
| Public Comment
 
| n/a
 
| n/a
 
| v2.0 is an update of v1.0 without additional public comment
 
| v2.0 is an update of v1.0 without additional public comment
 
|-
 
|-
−
| [[Media:QIBA_99mTC SPECT 2020-05-12.pdf| SPECT 99mTC 2020-05-12]]
+
|[[Media:QIBA 99mTC SPECT 2020-05-12.pdf| SPECT 99mTC 2020-05-12]]
 
| Public Comment
 
| Public Comment
 
| 2020.02.03
 
| 2020.02.03
−
| [[Media:QIBA_99mTC SPECT Comments_all resolved.xlsx| Public Comment Resolutions 2020-08-11]]
+
|[[Media:QIBA 99mTC SPECT Comments 2020-08-11-final.xlsx| Public Comment Resolutions 2020-08-11]]
 
|-
 
|-
 
| colspan="4" align="center" style="background:#dddddd" | '''Ultrasound Profiles'''
 
| colspan="4" align="center" style="background:#dddddd" | '''Ultrasound Profiles'''
 
|-
 
|-
−
| [[Media:QIBA_US_SWS_Profile_10.21.19.pdf|US Shear Wave Speed for Liver Fibrosis 2019-10-21]]
+
| [[Media:QIBA US SWS Profile 10.21.19.pdf|US Shear Wave Speed for Liver Fibrosis 2019-10-21]]
 
| Public Comment
 
| Public Comment
 
| 2019.12.18
 
| 2019.12.18
−
| '''Resolving Feedback'''
+
| [[Media:QIBA US SWS Comments 2021-02-06-final.xlsx| Public Comment Resolutions 2021-02-06]]
 +
|-
 +
| [[Media:QIBA US SWS Profile 2023-02-07.pdf|US Shear Wave Speed for Liver Fibrosis 2023-02-07]]
 +
| Clinically Feasible
 +
| 2023.02.07
 +
| [[Media:QIBA US SWS Comments 2023-02-20-v2.xlsx| Clinically Feasible Comment Resolutions 2023-02-20]]
 +
|-
 +
| [[Media:QIBA US SWS Profile 2023-02-07.pdf|US Shear Wave Speed for Liver Fibrosis 2023-02-07, marked-up version]]
 +
| Clinically Feasible
 +
| 2023.12.13
 +
| [[Media:2023 12 13 SWS BC QIBA Technical Confirmation Resolutions.xlsx| Clinically Feasible Comment Resolutions 2023-12-13]]
 +
|-
 +
| [[Media:SWS Profile Final Candidate February 07 2023 CLEAN.pdf|US Shear Wave Speed for Liver Fibrosis 2023-02-07, clean version]]
 +
| Clinically Feasible
 +
| 2023.12.13
 +
| [[Media:2023 12 13 SWS BC QIBA Technical Confirmation Resolutions.xlsx| Clinically Feasible Comment Resolutions 2023-12-13]]
 +
|-
 +
| [[Media:QIBA US VBF Profile 2023-12-13-tracked-changes.pdf|US Volume Blood Flow (VBF) Profile 2023-12-13 (tracked changes)]]
 +
| Consensus
 +
| 2023.12.13
 +
| [[Media:2023 12 13 VBF BC QIBA Consensus Confirmation Resolutions.xlsx| Consensus Comment Resolutions 2023-12-13]]
 
|-
 
|-
 +
|}

Latest revision as of 14:53, 21 December 2023

Comments received during Public Comment, Clinically Feasible (formerly Technical) Confirmation, or during a Profile ballot, are reviewed by the originating Biomarker Committee.

Per the QIBA Process, committees record how each collected comment was resolved and those resolutions are posted here.


Profile Document Feedback Type Feedback Closed Resolutions
CT Profiles
CT Small Lung Nodule Screening 2016-06-01 Public Comment 2016.09 Public Comment Resolutions 2018-06-15
CT Tumor Volumetry for Advanced Disease 2016-11-21b Technical Confirmation 2017.02 Technical Confirmation Resolutions 2018-02-25
CT Atherosclerosis 2020-03-10 Public Comment 2019.06.03 Public Comment Resolutions 2020-03-12
CT Atherosclerosis 2023-03-28 Clinically Feasible 2023.03.07 Clinically Feasible Comment Resolutions 2023-03-28
CT Lung Density 2020-09-04 Public Comment 2019.10.16 Public Comment Resolutions 2020-09-04
CT Small Lung Nodule Screening 2018-11-18 Technical Confirmation 2020.04 Clinically Feasible Comment Resolutions 2023-08-18
MR Profiles
MR Elastography 2017-08-15 Public Comment 2017.09.15 Public comment Resolutions
fMRI Sensorimotor 2017-06-19 Public Comment 2017.12.31 Resolving Feedback
MR DWI 2019-02-05 Public Comment #2 2019.04.05 Public Comment Resolutions
MR Dynamic Susceptibility Contrast (DSC-MRI) 2020-01-29 Public Comment 2020.05.15 Public Comment Resolutions
MR MSK cartilage compositional biomarkers (T1ρ,T2) 2020-05-18 Public Comment 2020.10.29 Public Comment Resolutions
MR DCE-MRI Quantification (DCEMRI-Q) 2023-12-06 Consensus 2023.12-06 Public Comment Resolutions
MR Elastography of the Liver 2022-02-14 Technical Confirmation 2021.12.16 Technical Confirmation Resolutions 2022-02-14
MR Diffusion-Weighted Imaging (DWI) of the Apparent Diffusion Coefficient (ADC) 2022-12-15 Clinically Feasible 2022.12.15 Clinically Feasible Resolutions 2022-12-15
MR MRI-Based Proton Density Fat Fraction (PDFF) of the Liver 2023-12-04 Consensus 2023.09.08 Public Comment Resolutions 2023-11-14
PET/NM Profiles
SPECT Ioflupane in Neurodegenerative Disease v1.1 Public Comment 2016.12.31 Public Comment Resolutions 2017-06-06
PET Amyloid 2019-06-15 Technical Confirmation 2021 Technical Confirmation Resolutions, 2022-04-15
PET Amyloid 2017-06-15 Public Comment 2017.09.15 Public Comment Resolutions 2018-05-02
SPECT Ioflupane in Neurodegenerative Disease v2.0, 2019-10-15 Public Comment n/a v2.0 is an update of v1.0 without additional public comment
SPECT 99mTC 2020-05-12 Public Comment 2020.02.03 Public Comment Resolutions 2020-08-11
Ultrasound Profiles
US Shear Wave Speed for Liver Fibrosis 2019-10-21 Public Comment 2019.12.18 Public Comment Resolutions 2021-02-06
US Shear Wave Speed for Liver Fibrosis 2023-02-07 Clinically Feasible 2023.02.07 Clinically Feasible Comment Resolutions 2023-02-20
US Shear Wave Speed for Liver Fibrosis 2023-02-07, marked-up version Clinically Feasible 2023.12.13 Clinically Feasible Comment Resolutions 2023-12-13
US Shear Wave Speed for Liver Fibrosis 2023-02-07, clean version Clinically Feasible 2023.12.13 Clinically Feasible Comment Resolutions 2023-12-13
US Volume Blood Flow (VBF) Profile 2023-12-13 (tracked changes) Consensus 2023.12.13 Consensus Comment Resolutions 2023-12-13
Retrieved from "https://qibawiki.rsna.org/index.php?title=Comment_Resolutions&oldid=19448"